Long term follow-up for DR-TB treatment

Long Term follow up

• Patients who completed TB treatment remain at risk of TB recurrence (re-infection or relapse). TB patients require regular follow-up starting from the treatment initiation until two years after successful treatment completion to achieve the desired outcome of recurrence-free survival.
• Hence, the programme introduced patient assessment at 6, 12, 18 and 24 months after completion of treatment. 

           The following indicator would be used to monitor this.

Sustained treatment success

• An individual assessed at six months (for DR-TB and DS-TB) and at 12 months (for DR-TB only) after successful TB treatment who is alive and free of TB (30).